Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters








Database
Language
Publication year range
1.
JAMA ; 332(6): 449-450, 2024 08 13.
Article in English | MEDLINE | ID: mdl-39008321

ABSTRACT

This Viewpoint explores a 2023 Biden administration proposal for US agencies to use their march-in rights and the impact this proposed framework could have on drug prices.


Subject(s)
Drug Costs , Drug Industry , Humans , Drug Costs/legislation & jurisprudence , Drug Industry/economics , Drug Industry/legislation & jurisprudence , United States , Federal Government
SELECTION OF CITATIONS
SEARCH DETAIL